APA

Lokhorst H. M., van der Holt B., Cornelissen J. J., Kersten M. J., van Oers M., Raymakers R., Minnema M. C., Zweegman S., Bos G., Schaap N., Wittebol S., de Weerdt O., Ammerlaan R. & Sonneveld P. (20160930). Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. : Haematologica.

Chicago

Lokhorst Henk M, van der Holt Bronno, Cornelissen Jan J, Kersten Marie José, van Oers Marinus, Raymakers Reinier, Minnema Monique C, Zweegman Sonja, Bos Gerard, Schaap Nicolaas, Wittebol Shulamiet, de Weerdt Okke, Ammerlaan Rianne and Sonneveld Pieter. 20160930. Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. : Haematologica.

Harvard

Lokhorst H. M., van der Holt B., Cornelissen J. J., Kersten M. J., van Oers M., Raymakers R., Minnema M. C., Zweegman S., Bos G., Schaap N., Wittebol S., de Weerdt O., Ammerlaan R. and Sonneveld P. (20160930). Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. : Haematologica.

MLA

Lokhorst Henk M, van der Holt Bronno, Cornelissen Jan J, Kersten Marie José, van Oers Marinus, Raymakers Reinier, Minnema Monique C, Zweegman Sonja, Bos Gerard, Schaap Nicolaas, Wittebol Shulamiet, de Weerdt Okke, Ammerlaan Rianne and Sonneveld Pieter. Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. : Haematologica. 20160930.